Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.

Abstract : By mimicking sympathetic stimulation in vivo, we previously reported that mice globally lacking serotonin 5-HT(2B) receptors did not develop isoproterenol-induced left ventricular hypertrophy. However, the exact cardiac cell type(s) expressing 5-HT(2B) receptors (cardiomyocytes versus noncardiomyocytes) involved in pathological heart hypertrophy was never addressed in vivo. We report here that mice expressing the 5-HT(2B) receptor solely in cardiomyocytes, like global 5-HT(2B) receptor-null mice, are resistant to isoproterenol-induced cardiac hypertrophy and dysfunction, as well as to isoproterenol-induced increases in cytokine plasma-levels. These data reveal a key role of noncardiomyocytes in isoproterenol-induced hypertrophy in vivo. Interestingly, we show that primary cultures of angiotensinogen null adult cardiac fibroblasts are releasing cytokines on stimulation with either angiotensin II or serotonin, but not in response to isoproterenol stimulation, demonstrating a critical role of angiotensinogen in adrenergic-dependent cytokine production. We then show a functional interdependence between AT(1)Rs and 5-HT(2B) receptors in fibroblasts by revealing a transinhibition mechanism that may involve heterodimeric receptor complexes. Both serotonin- and angiotensin II-dependent cytokine production occur via a Src/heparin-binding epidermal growth factor-dependent transactivation of epidermal growth factor receptors in cardiac fibroblasts, supporting a common signaling pathway. Finally, we demonstrate that 5-HT(2B) receptors are overexpressed in hearts from patients with congestive heart failure, this overexpression being positively correlated with cytokine and norepinephrine plasma levels. Collectively, these results reveal for the first time that interactions between AT(1) and 5-HT(2B) receptors coexpressed by noncardiomyocytes are limiting key events in adrenergic agonist-induced, angiotensin-dependent cardiac hypertrophy. Accordingly, antagonists of 5-HT(2B) receptors might represent novel therapeutics for sympathetic overstimulation-dependent heart failure.
Type de document :
Article dans une revue
Circulation Research, American Heart Association, 2009, 104 (1), pp.113-23. 〈10.1161/CIRCRESAHA.108.180976〉
Liste complète des métadonnées

Littérature citée [43 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00484528
Contributeur : Luc Maroteaux <>
Soumis le : vendredi 29 avril 2011 - 19:20:56
Dernière modification le : vendredi 31 août 2018 - 08:46:10
Document(s) archivé(s) le : samedi 30 juillet 2011 - 02:32:05

Fichier

CircRes104_113_Jaffre.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Fabrice Jaffré, Philippe Bonnin, Jacques Callebert, Haythem Debbabi, Vincent Setola, et al.. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.. Circulation Research, American Heart Association, 2009, 104 (1), pp.113-23. 〈10.1161/CIRCRESAHA.108.180976〉. 〈inserm-00484528〉

Partager

Métriques

Consultations de la notice

379

Téléchargements de fichiers

356